<code id='E9CCCE2C99'></code><style id='E9CCCE2C99'></style>
    • <acronym id='E9CCCE2C99'></acronym>
      <center id='E9CCCE2C99'><center id='E9CCCE2C99'><tfoot id='E9CCCE2C99'></tfoot></center><abbr id='E9CCCE2C99'><dir id='E9CCCE2C99'><tfoot id='E9CCCE2C99'></tfoot><noframes id='E9CCCE2C99'>

    • <optgroup id='E9CCCE2C99'><strike id='E9CCCE2C99'><sup id='E9CCCE2C99'></sup></strike><code id='E9CCCE2C99'></code></optgroup>
        1. <b id='E9CCCE2C99'><label id='E9CCCE2C99'><select id='E9CCCE2C99'><dt id='E9CCCE2C99'><span id='E9CCCE2C99'></span></dt></select></label></b><u id='E9CCCE2C99'></u>
          <i id='E9CCCE2C99'><strike id='E9CCCE2C99'><tt id='E9CCCE2C99'><pre id='E9CCCE2C99'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:entertainment    Page View:51978
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          FDA panel signals lack of confidence in Amgen cancer drug data
          FDA panel signals lack of confidence in Amgen cancer drug data

          AdobeTheclearanceofafirst-of-its-kindcancertreatmentmadebyAmgenisonshakiergroundfollowingaFoodandDru

          read more
          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more

          FDA needs staff influx to meet gene therapy needs, Marks says

          FDA'sPeterMarksJIMLOSCALZO/POOL/AFPviaGettyImagesWASHINGTON—TheFoodandDrugAdministrationneedsdozensm